Navigation Links
Growth Fuels Expansion As PendoTECH Relocates New Jersey Headquarters
Date:3/19/2013

PRINCETON, N.J., March 19, 2013 /PRNewswire-iReach/ -- PendoTECH, a company dedicated to designing products to optimize the bioprocess, announced today that it has relocated its regional headquarters to an expanded facility in Princeton, NJ.  The office space will serve as the company's local base of operation now that it has moved out of its former facility of 5 years.

"We are pleased to announce our relocation within the Princeton, NJ area; home to some of the biggest pharmaceutical companies in the country and in the heart of the state designated industry cluster known as Einstein's Alley (www.einsteinsalley.org )," shares PendoTECH's James Furey .  "The new office includes upgraded amenities such as client meeting rooms, expanded reception area, product showroom, a state-of-the-art laboratory and space for future growth.  The move will enable greater access to our current and emerging clients."

A pioneer in the area of in-line, low cost sensory technology, PendoTECH is one of the most recognized brands known for enhancing the production process for biopharmaceuticals such as antibodies, recombinant proteins, vaccines, gene therapy and cell therapy products.   The need for a larger office became more pressing due to a steady increase in product demands. 

About PendoTECH
PendoTECH is committed to providing value-added products and services to companies in the biopharmaceutical industry for enhanced development and production of products derived mainly from biological systems.   Products include Single Use Pressure Sensors, PressureMAT- a monitor, alarm, and transmitter system designed for use with the pressure sensors, and our integrated Process Control Systems for applications such as TFF/Crossflow Filtration, Filter Screening, Virus-Depth Filtration, Bioreactor Pressure Control/Monitoring and more. 

As the number of biologicals produced by cell culture increases and the industry matures, new technologies and process approaches are available for comparison to the existing ones for evaluation of enhanced production output and reduced cost of goods.  Contact us at http://www.pendotech.com/ or 609-799-2299 for more information. 



Media Contact: Jim Furey PendoTECH, 609-799-2299, tashieka@pendotech.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE PendoTECH
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth
2. Endocrinology Market to 2018 - Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease of Use for Patients
3. Amgen to Present at the Baird Growth Stock Conference
4. Veeva Systems Announces Dramatic Growth in Europe
5. Aethlon Medical to Present at Todays Security Research Associates 8th Annual Growth Conference
6. Contract Research Organizations Set to Experience Rapid Growth as Development Costs for New Drugs Continue to Rise
7. Millennium Surgical Corp. Announces Sales Figures, Growth
8. MicroRNA Research to Trigger Tremendous Growth in Related Tools Market, Says Frost & Sullivan
9. Masimo to Present at William Blair & Company 32nd Annual Growth Stock Conference
10. VitaTech Adds New Capacity for Production and Customer Interface, Attributes Growth to Strategic Customer Partnerships
11. Perrigo Company To Present At The William Blair Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... BOCA RATON, Fla. , Jan. 19, 2017 ... ), a medical device company specializing in the ... conditions, such as keloids, with superficial radiation therapy, ... quarter and full year 2016 financial results on Thursday, ... The Company will hold a conference call ...
(Date:1/19/2017)... 19, 2017 Shire plc (LSE: ... U.S. Food and Drug Administration (FDA) has acknowledged receipt ... Application (NDA) for SHP465, a long-acting, triple-bead, mixed amphetamine ... once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is ... 20, 2017, the designated Prescription Drug User Fee Act ...
(Date:1/19/2017)... January 19, 2017 Pfizer ... the Milner Therapeutics Consortium   Major ... Cambridge   The Milner ... PFE ) as a partner to the Milner Therapeutics ... enables the efficient transfer of materials between industry and ...
Breaking Medicine Technology:
(Date:1/20/2017)... , ... January 20, 2017 , ... Michael and Betsy ... Farber Cancer Institute. For Betsy, the clinical trial has been life-saving as she ... not worsened. , Betsy Brauser was diagnosed with ovarian cancer in 2009. She ...
(Date:1/20/2017)... ... 20, 2017 , ... “Mary Magdalene: Grace is Greater than Sin”: a ... witnessed Jesus Christ firsthand. “Mary Magdalene: Grace is Greater than Sin” is the creation ... educator interacting with countless women who had little knowledge of the female characters portrayed ...
(Date:1/20/2017)... ... ... fine examination of how God handles sin, including how to let go of lingering guilt ... over ten long years has been waiting to release this powerful insight about forgiveness that ... serving the Lord for over twenty years, and he has been preaching and teaching the ...
(Date:1/20/2017)... ... ... Christmas:” a beautiful and enchanting tale that teaches children the true meaning of Christmas. “Journey ... Oklahoma City, and a devoted woman of faith. , “Becoming a parent changes you. ... of my mind for years, but actually doing it might have been a while in ...
(Date:1/20/2017)... , ... January 20, 2017 , ... “God's Miracle Man: ... All Odds” is the creation of published author, Keith C. A. Tucker, son of ... Christian Fellowship World Outreach pastured by Reverend Mark Hardy , “While sitting up in ...
Breaking Medicine News(10 mins):